2025 annual financial data
CNS Pharmaceuticals 2025 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -15,986,559 USD and net income was -15,850,564 USD.
Operating cash flow was -13,811,107 USD.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -15,986,559 USD
- Net income
- -15,850,564 USD
- Operating cash flow
- -13,811,107 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all CNS Pharmaceuticals financial years